Showing 1 - 6 results of 6 for search 'V. Bücklein', query time: 0.03s Refine Results
  1. 1
    PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT

    PB2210: FAVORABLE OUTCOME AFTER SECOND CD19 CAR T INFUSION OF AN IDENTICAL PRODUCT: HOST ENVIRONMENT AND DISEASE CHARACTERISTICS DETERMINE THE OUTCOME OF TREATMENT by L. Frölich, V. Blumenberg, K. Rejeski, C. Schmidt, M. Winkelmann, F. Schöberl, L. von Baumgarten, W. Kunz, V. Bücklein, M. Subklewe

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P1445: MYTCELL®: AN INTERACTIVE SMARTPHONE APPLICATION FOR CARS AND BITES INCREASES GUIDELINE ACCESSIBILITY AND REDUCES TIME TO APPLY EVIDENCE-BASED PATIENT CARE

    P1445: MYTCELL®: AN INTERACTIVE SMARTPHONE APPLICATION FOR CARS AND BITES INCREASES GUIDELINE ACCESSIBILITY AND REDUCES TIME TO APPLY EVIDENCE-BASED PATIENT CARE by V. Blumenberg, L. Siegmund, L. Frölich, K. Rejeski, M. Warm, F. Hildebrand, C. Schmidt, M. von Bergwelt, V. Bücklein, M. Subklewe

    Published 2022-06-01
    Get full text
    Article
  3. 3
    P1438: PROCALCITONIN IS ELEVATED IN SEVERE INFECTIONS AFTER CD19 CAR-T IN R/R B-NHL AND ENABLES DISCRIMINATION OF EARLY INFECTIONS FROM CRS – PARTICULARLY IN COMBINATION WITH THE CAR-HEMATOTOX SCORE

    P1438: PROCALCITONIN IS ELEVATED IN SEVERE INFECTIONS AFTER CD19 CAR-T IN R/R B-NHL AND ENABLES DISCRIMINATION OF EARLY INFECTIONS FROM CRS – PARTICULARLY IN COMBINATION WITH THE C... by K. Rejeski, V. Blumenberg, F. Hildebrand, L. Frölich, P. Karschnia, M. Dreyling, M. von Bergwelt-Baildon, C. Schmidt, M. Subklewe, V. Bücklein

    Published 2022-06-01
    Get full text
    Article
  4. 4
    P433: ADAPTER HOLIDAYS MAINTAIN IN-VITRO ADCAR-T CELL FUNCTIONALITY AGAINST AML

    P433: ADAPTER HOLIDAYS MAINTAIN IN-VITRO ADCAR-T CELL FUNCTIONALITY AGAINST AML by D. Nixdorf, M. Sponheimer, D. Berghammer, N. Zieger, L. Rohrbacher, S. Dapa, C. M. Seitz, K. Brandstetter, M. von Bergwelt-Baildon, H. Leonhardt, J. Mittelstaet, A. Kaiser, V. Bücklein, M. Subklewe

    Published 2022-06-01
    Get full text
    Article
  5. 5
    P1458: PATTERNS OF LONG-TERM HEMATOPOIETIC RECOVERY IMPACT SURVIVAL OUTCOMES AFTER CD19-DIRECTED CAR T-CELL THERAPY FOR R/R LBCL

    P1458: PATTERNS OF LONG-TERM HEMATOPOIETIC RECOVERY IMPACT SURVIVAL OUTCOMES AFTER CD19-DIRECTED CAR T-CELL THERAPY FOR R/R LBCL by K. Rejeski, O. Albanyan, G. Iacoboni, V. Bücklein, V. Blumenberg, O. Penack, W. Bethge, S. Völkl, A. Perez, C. Carpio, C. Schmidt, N. Müller, K. Reid, R. Faramand, M. Davila, L. Bullinger, F. Locke, M. von Bergwelt-Baildon, A. Mackensen, P. Barba, M. Jain, M. Subklewe

    Published 2022-06-01
    Get full text
    Article
  6. 6
    P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE

    P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CH... by V. Bücklein, A. Perez, G. Iacoboni, K. Rejeski, U. Holtick, O. Penack, S. Kharboutli, V. Blumenberg, J. Ackermann, L. Frölich, G. Johnson, K. Patel, B. Arciola, C. Schmidt, O. Albanyan, P. Gödel, E. Hoster, L. Bullinger, A. Mackensen, F. Locke, M. von Bergwelt, P. Barba, M. D. Jain, M. Subklewe

    Published 2022-06-01
    Get full text
    Article

Search Tools: